Trial Information

Summary: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

The Queens Cancer Center of Queens Hospital Center in conjunction with the Southwest Oncology Group and sponsored by the NCI (National Cancer Institute) is participating in a 12 year national study designed to test the effectiveness of Selenium and Vitamin E in the prevention of prostate cancer. This is the largest prostate cancer prevention study ever undertaken. Approximately 32,400 men at more than 400 sites throughout the United States are expected to participate. Selenium and Vitamin E were selected for this trial because of their demonstrated anticancer activity in two other large-scale cancer prevention trials.

You may be eligible to participate in the above study if you:

• Are age 55 or older (or age 50 or older for African-American men)
• Have never been diagnosed with prostate cancer or any other cancer except non-melanoma skin cancer in the last 5 years

• Are taking anticoagulant therapy (Coumadin)
• Have a history of stroke
• Have a history of retinitis pigmentosa (progressive degeneration of the retina of the eye)

You will not be compensated for your time, however, all FDA approved research study medication will be provided at no cost to you.

IRB APPROVAL: 8/29/02 - 8/14/03

If you would like to learn more about participating in this study, please send an e-mail message using the form below.